Grant: Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
University of Ottawa
$97,928.00
Role of the RNA-binding protein staufen in myotonic dystrophy type 1
EF 2008-09
Résumé
Myotonic dystrophy type 1 (DM) is caused by mutations in the DMPK gene. The presence of this mutation is thought to lead to aberrant patterns of interactions between proteins normally expressed in cells and mutant DMPK messenger RNAs. In turn, these aberrant interactions prevent these proteins from assuming their normal functions within DM cells thereby causing the many symptoms characteristic of this disease. The current proposal is designed to examine the role of one such protein, called Staufen, that interacts with DMPK messenger RNAs and whose expression and localization appear to be markedly affected in DM muscle. The identification of such protein and the elucidation of their functions in skeletal muscle are important since these studies may lead to the development of new therapeutic strategies for treating DM.
Programme
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
186523
Name
Jasmin Bernard J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Muscular Dystrophy Canada (Toronto, Ontario)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Cell Physiology
Projecttitle
Role of the RNA-binding protein staufen in myotonic dystrophy type 1
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$97,928
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Myotonic Dystrophy (Rachel Fund)
Keyworddelim
Molecular Biology; Myotonic Dystrophy; Post-Transcriptional Regulation; Rna-Binding Protein; Skeletal Muscle
Abstract
Myotonic dystrophy type 1 (DM) is caused by mutations in the DMPK gene. The presence of this mutation is thought to lead to aberrant patterns of interactions between proteins normally expressed in cells and mutant DMPK messenger RNAs. In turn, these aberrant interactions prevent these proteins from assuming their normal functions within DM cells thereby causing the many symptoms characteristic of this disease. The current proposal is designed to examine the role of one such protein, called Staufen, that interacts with DMPK messenger RNAs and whose expression and localization appear to be markedly affected in DM muscle. The identification of such protein and the elucidation of their functions in skeletal muscle are important since these studies may lead to the development of new therapeutic strategies for treating DM.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jasmin, Bernard J
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $97,928~ $0~